These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12895200)

  • 41. Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection.
    Akay BN; Ekmekci P; Sanli H; Celik G; Bozdayi M
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):442-5. PubMed ID: 16643145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Consensus interferon: a new weapon in the treatment of chronic hepatitis C].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(3):211-2. PubMed ID: 10958058
    [No Abstract]   [Full Text] [Related]  

  • 43. Late onset autoimmune thrombocytopenia associated with pegylated interferon-alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Elefsiniotis IS; Pantazis KD; Fotos NV; Moulakakis A; Mavrogiannis C
    J Gastroenterol Hepatol; 2006 Mar; 21(3):622-3. PubMed ID: 16638114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pulmonary sarcoidosis--a rare complication of interferon treatment for chronic hepatitis C].
    Pellová A; Pella J; Schréter I; Somos A; Kristian P; Boom A
    Klin Mikrobiol Infekc Lek; 2006 Oct; 12(5):200-2. PubMed ID: 17080355
    [No Abstract]   [Full Text] [Related]  

  • 45. [Acute pericardite which has occurred during the treatment of chronic hepatitis C by the interferon alpha2A].
    Hamdani I; Kochlef A; Belhadj N; Kharrat J; Ghorbel A
    Tunis Med; 2008 Apr; 86(4):404-5. PubMed ID: 19476158
    [No Abstract]   [Full Text] [Related]  

  • 46. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
    Papaioannides D; Fotinou M; Korantzopoulos P; Latsi P; Sinapidis D; Akritidis N; Orphanidou D
    Med Sci Monit; 2004 Jan; 10(1):CS5-7. PubMed ID: 14704637
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 48. Minimal change disease in a patient receiving IFN-alpha therapy for chronic hepatitis C virus infection.
    Dizer U; Beker CM; Yavuz I; Ortatatli M; Ozguven V; Pahsa A
    J Interferon Cytokine Res; 2003 Jan; 23(1):51-4. PubMed ID: 12639299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Onset of dermatitis herpetiformis after treatment by interferon and ribavirin for chronic hepatitis C.
    Borghi-Scoazec G; Merle P; Scoazec JY; Claudy A; Trepo C
    J Hepatol; 2004 May; 40(5):871-2. PubMed ID: 15094241
    [No Abstract]   [Full Text] [Related]  

  • 50. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C.
    Soultati AS; Dourakis SP; Alexopoulou A; Deutsch M; Archimandritis AJ
    World J Gastroenterol; 2007 Feb; 13(8):1292-4. PubMed ID: 17451219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tongue hyperpigmentation during interferon therapy.
    Karabay O; Goksugur N; Ogutlu A
    J Dermatol; 2011 Mar; 38(3):290-1. PubMed ID: 21342236
    [No Abstract]   [Full Text] [Related]  

  • 52. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C.
    Lambotte O; Gelu-Simeon M; Maigne G; Kotb R; Buffet C; Delfraissy JF; Goujard C
    J Infect; 2005 Oct; 51(3):e113-5. PubMed ID: 16230187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continued treatment of chronic hepatitis C despite development of interferon-associated retinopathy.
    Cedar MA; Zancosky KL; Oliva LA; Molloy PJ; Weissgold DJ; Krawitt EL
    Am J Gastroenterol; 2007 Nov; 102(11):2612-3. PubMed ID: 17958775
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia.
    Brinovec V; Lesnicar G; Maticic M; Meglic-Volkar J; Poljak M; Seme K; Ferlan-Marolt V
    Hepatogastroenterology; 2002; 49(47):1320-5. PubMed ID: 12239935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infergen (interferon alfacon-1).
    Gastroenterol Nurs; 1998; 21(1):30-1. PubMed ID: 9555366
    [No Abstract]   [Full Text] [Related]  

  • 57. Dry cough and optic neuritis: two rare complications of interferon alpha treatment in chronic viral hepatitis.
    Isler M; Akhan G; Bardak Y; Akkaya A
    Am J Gastroenterol; 2001 Apr; 96(4):1303-4. PubMed ID: 11316196
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C.
    Tahan V; Tahan G; Dane F; Uraz S; Yardim M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):224-5. PubMed ID: 17592576
    [No Abstract]   [Full Text] [Related]  

  • 59. Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
    Kasahara A; Hiraide A; Tomita N; Iwahashi H; Imagawa A; Ohguro N; Yamamoto S; Mita E; Hayashi N
    J Gastroenterol; 2004 Nov; 39(11):1106-9. PubMed ID: 15580406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.